World's Best Scientists 2026 revealed!
Georgia D. Tomaras

Georgia D. Tomaras

D-Index & Metrics

Immunology

D-Index
91
Citations
32352
World Ranking
1033
National Ranking
559

Medicine

D-Index
91
Citations
32352
World Ranking
11709
National Ranking
6006

Georgia D. Tomaras publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Georgia D. Tomaras sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 383 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Georgia D. Tomaras D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Georgia D. Tomaras sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 91 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2018 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Georgia D. Tomaras is affiliated with Duke University in the United States. Their research primarily focuses on immunology and microbiology, with a strong emphasis on virology, infectious diseases, and molecular biology. The scholar's work is concentrated around HIV research and treatment, monoclonal and polyclonal antibodies, and vaccine development using immunoinformatics approaches. They also study immune cell function, immunotherapy, and T-cell and B-cell immunology.

Key recent publications authored or co-authored by Georgia D. Tomaras include:

  • Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study, 2021, Science
  • Vaccination induces HIV broadly neutralizing antibody precursors in humans, 2022, Science
  • 3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates, 2020, Science Immunology
  • Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial, 2022, Nature Medicine
  • Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition, 2022, Nature Medicine

Frequently collaborating co-authors include:

  • David C. Montefiori
  • Kelly E. Seaton
  • Guido Ferrari
  • Lawrence Corey
  • M. Juliana McElrath

Georgia D. Tomaras has contributed extensively to several publication venues, notably:

  • UNC Libraries
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • PLoS Pathogens
  • npj Vaccines

Their research covers a broad spectrum of topics including:

  • HIV Research and Treatment
  • Monoclonal and Polyclonal Antibodies Research
  • HIV/AIDS drug development and treatment
  • Vaccines and immunoinformatics approaches
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • T-cell and B-cell Immunology

In 2018, Georgia D. Tomaras was recognized as a Fellow of the American Association for the Advancement of Science (AAAS).

Best Publications

  • Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

    Brandon F. Keele;Elena E. Giorgi;Elena E. Giorgi;Jesus F. Salazar-Gonzalez;Julie M. Decker

  • Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

    Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner

  • The immune response during acute HIV-1 infection: clues for vaccine development.

    Andrew J. McMichael;Persephone Borrow;Georgia D. Tomaras;Nilu Goonetilleke

  • Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

    Georgia D. Tomaras;Nicole L. Yates;Pinghuang Liu;Li Qin

  • Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

    Scott M. Hammer;Magdalena E. Sobieszczyk;Holly Janes;Shelly T. Karuna

  • Combination therapy with anti-HIV-1 antibodies maintains viral suppression

    Pilar Mendoza;Henning Gruell;Lilian Nogueira;Joy A. Pai

  • Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors

    Mattia Bonsignori;Kwan Ki Hwang;Xi Chen;Chun Yen Tsao

  • Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination

    Nicole L. Yates;Nicole L. Yates;Hua Xin Liao;Hua Xin Liao;Youyi Fong;Allan DeCamp

  • Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family

    Mattia Bonsignori;Justin Pollara;M. Anthony Moody;Michael D. Alpert

  • Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG

    Georgia D. Tomaras;Guido Ferrari;Xiaoying Shen;S. Munir Alam

  • Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

    Hua Xin Liao;Mattia Bonsignori;S. Munir Alam;Jason S. McLellan

  • Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C

    James M. Binley;Elizabeth A. Lybarger;Emma T. Crooks;Michael S. Seaman

  • Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers.

    Olivier Lambotte;Guido Ferrari;Christiane Moog;Nicole L Yates

  • CD4 T follicular helper cell dynamics during SIV infection

    Constantinos Petrovas;Takuya Yamamoto;Michael Y. Gerner;Kristin L. Boswell

  • CXCL13 is a plasma biomarker of germinal center activity

    Colin Havenar-Daughton;Madelene Lindqvist;Antje Heit;Jennifer E. Wu

  • Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

    Dan H Barouch;Dan H Barouch;Frank L Tomaka;Frank Wegmann;Daniel J Stieh

  • An HIV-1 gp120 Envelope Human Monoclonal Antibody That Recognizes a C1 Conformational Epitope Mediates Potent Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity and Defines a Common ADCC Epitope in Human HIV-1 Serum

    Guido Ferrari;Justin Pollara;Daniel Kozink;Tiara Harms

  • Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study.

    Kathryn M. Hastie;Haoyang Li;Daniel Bedinger;Sharon L. Schendel

  • Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection

    Susan Zolla-Pazner;Allan DeCamp;Peter B. Gilbert;Constance Williams

  • COMPASS identifies T-cell subsets correlated with clinical outcomes

    Lin Lin;Greg Finak;Kevin Ushey;Chetan Seshadri

Frequent Co-Authors

David C. Montefiori
David C. Montefiori Duke University
Barton F. Haynes
Barton F. Haynes Duke University
Guido Ferrari
Guido Ferrari Duke University
Hua-Xin Liao
Hua-Xin Liao Duke University
M. Juliana McElrath
M. Juliana McElrath University of Washington
M. Anthony Moody
M. Anthony Moody Duke University
Peter B. Gilbert
Peter B. Gilbert Fred Hutchinson Cancer Research Center
S. Munir Alam
S. Munir Alam Duke University
Nelson L. Michael
Nelson L. Michael Walter Reed Army Institute of Research
Robert Parks
Robert Parks Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees online can open diverse career pathways. Many students transition into nursing roles, which complement immunological knowledge and offer hands-on patient care experience. Programs like accelerated nurse practitioner programs provide a fast track for those with prior degrees who want to enter advanced clinical roles swiftly.

Non-nurses exploring a career change might consider online RN programs for non nurses, designed to bridge the gap without traditional nursing backgrounds. These programs boast flexible structures to fit diverse educational histories, making them an accessible entry point.

For quicker entry into the nursing profession, options like the easiest accelerated nursing programs to get into can be appealing. These programs often have more flexible admission criteria while maintaining essential curriculum standards.

Similarly, individuals aiming for licensed practical nurse roles can explore LPN programs with easiest admission requirements, which offer a quicker, more accessible pathway into the nursing field. Combining these degrees with immunology expertise can enhance career flexibility and opportunities in healthcare settings.

Best Scientists Citing Georgia D. Tomaras

Trending Scientists

Recently Published Articles